Formosa Pharmaceuticals, Inc. (TPE:6838)
Taiwan · Delayed Price · Currency is TWD 27.00
-0.15 (-0.55%)
At close: Feb 10, 2026
Formosa Pharmaceuticals Market Cap
Formosa Pharmaceuticals has a market cap or net worth of 4.1 billion as of February 10, 2026. Its market cap has decreased by -20.73% in one year.
Market Cap
4.10B
Enterprise Value
2.61B
Revenue
12.16M
Ranking
n/a
PE Ratio
n/a
Stock Price
27.00
Market Cap Chart
Since October 7, 2021, Formosa Pharmaceuticals's market cap has decreased from 5.53B to 4.10B, a decrease of -25.94%. That is a compound annual growth rate of -6.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 4.08B | 2.27% |
| Dec 31, 2025 | 3.99B | -29.51% |
| Dec 31, 2024 | 5.65B | -15.62% |
| Dec 29, 2023 | 6.70B | 13.17% |
| Dec 30, 2022 | 5.92B | 74.66% |
| Dec 30, 2021 | 3.39B | -38.75% |
| Oct 7, 2021 | 5.53B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AnnJi Pharmaceutical | 4.72B |
| Senhwa Biosciences | 4.66B |
| BioGend Therapeutics | 4.55B |
| Medigen Biotechnology | 4.40B |
| ACRO Biomedical | 4.27B |
| Energenesis Biomedical CO.,LTD. | 4.15B |
| BRIM Biotechnology | 3.84B |
| Genovate Biotechnology | 3.64B |